Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
18,092,627
-
Share change
-
-164,374
-
Total reported value
-
$2,316,027,490
-
Put/Call ratio
-
68%
-
Price per share
-
$128.12
-
Number of holders
-
189
-
Value change
-
-$19,637,838
-
Number of buys
-
81
-
Number of sells
-
93
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2014
As of 31 Mar 2014,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,092,627 shares.
The largest 10 holders included
ATLANTA CAPITAL MANAGEMENT CO L L C, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, LEVIN CAPITAL STRATEGIES, L.P., ROYCE & ASSOCIATES LLC, Champlain Investment Partners, LLC, WELLS FARGO & COMPANY/MN, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors.
This page lists
189
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.